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Background: The objective of the study was to estimate the personal usage of long-acting reversible
contraception (LARC) among obstetrics and gynecology (Ob/Gyn) residents in the United States
and compare usage between programs with and without a Ryan Residency Training Program (Ryan
Program), an educational program implemented to enhance resident training in family planning.
Materials and methods: We performed a web-based, cross-sectional survey to explore contraceptive use among Ob/Gyn residents between November and December 2014. Thirty-two
Ob/Gyn programs were invited to participate, and 24 programs (75%) agreed to participate. We
divided respondents into two groups based on whether or not their program had a Ryan Program.
We excluded male residents without a current female partner as well as residents who were
currently pregnant or trying to conceive. We evaluated predictors of LARC use using bivariate
analysis and multivariable Poisson regression.
Results: Of the 638 residents surveyed, 384 (60.2%) responded to our survey and 351 were
eligible for analysis. Of those analyzed, 49.3% (95% confidence interval [CI]: 44.1%, 54.5%)
reported current LARC use: 70.0% of residents in Ryan Programs compared to 26.8% in nonRyan Programs (RRadj 2.14, 95% CI 1.63–2.80). Residents reporting a religious affiliation were
less likely to use LARC than those who described themselves as non-religious (RRadj 0.76,
95% CI 0.64–0.92). Of residents reporting LARC use, 91% were using the levonorgestrel
intrauterine device.
Conclusion: LARC use in this population of women’s health specialists is substantially higher
than in the general population (49% vs. 12%). Ob/Gyn residents in programs affiliated with the
Ryan Program were more likely to use LARC.
Keywords: contraception, education, family planning, LARC, Ob/Gyn residents
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Long-acting reversible contraception (LARC) methods are the most effective reversible methods of pregnancy prevention.1 The three commonly used LARC methods
available in the United States (US) include the copper and levonorgestrel-containing
intrauterine devices (IUDs) and the subdermal etonogestrel implant. LARC uptake has
been particularly high within the family planning community, with one study demonstrating 41.7% of sampled providers using a LARC method.2 Uptake in the general
population is not nearly as high with recent data demonstrating an increase from 2.4%
in 2002 to 8.5% in 2009.3 These findings were corroborated by the recent data from
the National Survey of Family Growth showing that the percentage of women using
LARC were stable at 1.5% from 1988 until 2002 and increased to 7.2% by 2011.4 In
2015, the Guttmacher Institute quoted the most recent rate of LARC use in the US as
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11.6%.5 Low uptake of LARC can be attributed to many factors including cost, patient knowledge and access, and, lastly,
provider knowledge and bias. The Contraceptive CHOICE
Project demonstrated that when these barriers were removed,
LARC uptake could be as high as 75%.6,7 While all forms
of contraception are important and should be discussed with
patients, improving access to LARC has been identified by
the family planning community as one strategy to reduce
unintended pregnancy and abortion rates.7–9
Obstetrics and gynecology (Ob/Gyn) residents may be
among the most educated consumers of evidence-based family planning. Their training focuses on women’s health, which
specifically includes the provision of contraception. This, in
turn, should reflect a highly informed and knowledgeable
population of physicians and consumers. However, exposure
to contraception is not standardized across residency training
programs in the US. In 1999, the Kenneth J. Ryan Residency
Training Program (Ryan Program) was launched to integrate
and enhance family planning training for Ob/Gyn residents
in the US and Canada.10 The Ryan Program provides an
opportunity for Ob/Gyn residents to have a structured experience in abortion and contraception education. To date, 80
of the 243 (40%) US Ob/Gyn residencies have incorporated
the Ryan Program. While less than one-half of residencies
have a Ryan Program, the Accreditation Council of Graduate
Medical Education still requires that Ob/Gyn residency programs provide a structured didactic and clinical educational
experience in all methods of family planning, including all
reversible and permanent methods of contraception.11
Our study estimated the personal contraceptive use of
Ob/Gyn residents in the US and the percentage of residents
using the most effective reversible contraceptive methods.
We also evaluated the association of formalized contraceptive
training through the Ryan Program with the contraceptive
choices of current Ob/Gyn residents and/or their partners. We
hypothesized that a greater percentage of Ob/Gyn residents
were using LARC methods in comparison to the general
population and, secondarily, that residents exposed to the
Ryan Program would be more likely to use LARC methods
than residents in programs without Ryan training.

Materials and methods
Study design and data collection
Between November and December 2014, we performed a
nationwide survey of Ob/Gyn residents using a convenience
sample obtained from the American Congress of Obstetrics
and Gynecology website directory (www.acog.org).12 The
Institutional Review Board of Washington University in
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St. Louis approved this study for exempt status prior to participant recruitment. For efficiency, we gave preference to larger
programs with a greater number of residents in order to meet
our required sample size. Programs were selected based on
whether or not they had a Ryan Program. This information was
obtained from the Ryan Program website (www.ryanprogram.
org).13 We attempted to balance the Ryan/non-Ryan groups
by geographic region (e.g., Northeast, West, Midwest, etc.).
We approached 32 programs (3 with religious affiliation, 29
without religious affiliation), and ultimately the web-based
survey (developed using Research Electronic Data Capture)
was distributed to residents in 24 programs (638 residents
out of 5,000 active US residents, 13%) after introducing the
project to residency coordinators or program directors.14 Two
electronic invitations were sent to residency coordinators and/
or program directors. Study information and survey links were
sent via email to residents by their program coordinator and/
or director. Consent was implied by survey participation as it
was described as voluntary. Respondents were compensated
with a $5 electronic gift card after survey completion.
Our survey took approximately 10 minutes to complete.
The survey collected demographic characteristics as well as
current relationship status and respondent’s religious affiliation. Respondents were asked if they or their partner were
currently pregnant or trying to conceive. If the respondent
(or the respondent’s partner) was not currently pregnant or
trying to conceive, she/he was asked about her/his partner’s
current contraceptive method. Finally, respondents were
asked about factors affecting their method of choice.

Data analysis
We included all respondents in our initial analysis comparing
resident characteristics in Ryan versus non-Ryan Programs.
However, in our analysis of contraceptive use, we excluded
residents who were pregnant or trying to conceive, as well as
male respondents without female partners. Female respondents with female partners were included, as our assessment
of contraceptive use was not limited to pregnancy prevention.
All statistical analyses were performed using Stata
Software (v.11; StataCorp, College Station, Texas, USA).
Demographic characteristics were presented as means, standard deviations, and percentages stratified by Ryan Program
status. Student’s t-tests, chi-square tests, and Fisher’s exact
tests were used where appropriate to compare characteristics of Ryan Program residents to residents from programs
without a Ryan. We compared demographic characteristics
between respondents using a LARC method and those using
a non-LARC method. We evaluated predictors of LARC
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Results

use using bivariate analysis and Poisson regression with
robust error variance. This multivariable method provides an
unbiased estimate of the relative risk (RR) given a common
outcome (greater than 10%). Significant factors identified
in the bivariate analysis were included in the final adjusted
multivariable regression model.
We calculated our sample size based on an alpha level
of 0.05 and power of 80%. Use of LARC by non-Ryan residents was estimated to be 15%. Assuming a 2-fold increase
in LARC use among Ryan Program residents compared to
non-Ryan residents, we needed a sample size of 118 residents
per group. Given our sample of more than 180 per group, we
had >90% power to detect a statistically significant difference
(type II error rate <10%).

Of the 32 Ob/Gyn residency training programs invited to
participate, 11 sites with Ryan Programs and 13 sites without a Ryan Program (total=24 programs or 75%) agreed to
participate. Of the 638 residents in these 24 programs, 384
completed the web-based survey, with a survey response
rate of 60.2%.
In our analysis of Ryan versus non-Ryan respondents, we
excluded 7 male respondents without female partners. Twentysix participants were also excluded as they were pregnant or
trying to conceive. Thus, we were left with an analytic sample
of 351 participants (183 participants in Ryan Programs and
168 in non-Ryan Programs; Figure 1). Residents in Ryan
and non-Ryan Programs were similar with the exception of

Distributed
to 32
programs

384 survey
respondents
(24 programs)
7 male respondents
without female partner
377
analyzed
(97%)

191 respondents
in Ryan Programs
(51%)

8 trying to
conceive/
currently
pregnant
(4%)

186 respondents in
non-Ryan Programs
(49%)

183 not
attempting
conception
(96%)

128
using
LARC
(70%)

18 trying to
conceive/
currently
pregnant
(10%)

55 using
non-LARC
or no
method
(30%)

168 not
attempting
conception
(90%)

45
using
LARC
(27%)

123
using
non-LARC
or no method
(73%)

Figure 1 Participant flow diagram.
Abbreviation: LARC, long-acting reversible contraception; Ryan Program, Ryan Residency Training Program.
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reported personal religious affiliation, number of residents
pregnant or trying to conceive, and LARC use (Table 1).
Of the eligible respondents, when asked to name their
primary method of contraception, 49.3% (173/351) reported
using a LARC method, 43.6% (153/351) reported using a
Table 1 Characteristics of residents in Ryan vs. non-Ryan
affiliated Programs, all respondents (n=377)
Characteristic

Age
Race
Black
White
Others
Ethnicity
Hispanic
Non-Hispanic
Marital status
Married
Not married but partnered
No partner
Respondent/Partner sex
Female respondent, male
partner
Female respondent, female
partner
Female respondent, no partner
Male respondent, female
partner
Current level of training
Postgraduate year 1
Post graduate year-2
Postgraduate year 3
Postgraduate year 4
Religion
Agnostic, atheist, and none
Hindu, Islamic, Buddhist, other
Catholic
Christian, Mormon
Jewish
Protestant
Religion dichotomized
Agnostic, atheist, and none
Any religion
Currently pregnant or
trying to conceive
No
Yes
Current LARCa use
No
Yes

Ryan
(n=191)

Non-Ryan
(n=186)

Mean

SD

Mean

SD

29.0
N

2.1
%

28.9
N

2.2
%

9
154
27

4.7
81.1
14.2

13
155
18

7.0
83.3
9.7

14
175

7.4
92.6

5
179

2.7
97.3

87
74
30

45.5
38.7
15.7

89
68
29

47.8
36.6
15.6

147

77.0

133

71.5

0

0

3

1.6

31
13

16.2
6.8

30
20

16.1
10.8

51
52
43
45

26.7
27.2
22.5
23.6

35
50
46
55

18.8
26.9
24.7
29.6

P-value

0.62
0.29

0.06

0.89

0.16

0.26

Discussion
<0.01

70
16
24
33
29
19

36.6
8.4
12.6
17.3
15.2
9.9

36
11
49
66
8
16

19.4
5.9
26.3
35.5
4.3
8.6

36.6
63.4

36
150

19.4
80.6
0.04

183
8

95.8
4.2

168
18

90.3
9.7

55
128

30.1
70.0

123
45

73.2
26.8

<0.01

Notes: Column percentages do not always equal 100% as some survey questions
were not answered by the participants.
a
LARC including IUDs or implants.
Abbreviations: SD, standard deviation; LARC, long-acting reversible contraception;
IUD, intrauterine device; Ryan Pragram, Ryan Residency Training Program.
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In this analysis of contraceptive use, we found that approximately half of Ob/Gyn residents were using LARC methods,
Table 2 Current contraceptive method use (N=351)

<0.01
70
121

non-LARC method, and 7.1% (25/351) reported not using
a method. The most common LARC method used was
the levonorgestrel IUD (158/173, 91.3% of LARC users;
158/351, 45% of total cohort). The most commonly reported
non-LARC method was the combined oral contraceptive
pill (94/153, 61.4% of non-LARC users; 94/351, 26.8% of
total cohort). Table 2 demonstrates the method mix used by
respondents.
Demographic comparisons between LARC and nonLARC contraceptive users are presented in Table 3. LARC
use was reported by 70.0% (128/183) of residents affiliated
with a Ryan Program and 26.8% (45/168) by non-Ryan
Program residents (P<0.01). When we compared LARC
and non-LARC (including no method) users, we found no
statistically significant differences in age, race, marital status,
or current level of training. The 2 groups differed in response
to the most important reason they identified for choosing their
contraceptive method (Tables 3 and 4): respondents using
LARC reported the effectiveness of the method (82/173,
47.4%) and convenience/ease of use (43/173, 24.9%) to
be the most important factors. Non-LARC users reported
menstrual symptom control, including heavy bleeding,
and effectiveness of the method to be the most important
factors: 31.5% (56/178) and 28.1% (50/178), respectively.
After adjusting for differences among the groups, including
religion and reason for method of choice, residents in Ryan
Programs were found to be 2 times more likely (RR 2.14,
95% confidence interval 1.63–2.80) to use a LARC method
than their non-Ryan counterparts (Table 4).

Method

Frequency

%

LARC
Levonorgestrel intrauterine device
Copper intrauterine device
Subdermal implant
Non-LARC
Depot medroxyprogesterone acetate
Pills
Patch
Ring
Condoms
Abstinence
Sterilization (male or female)
Other
No method

173
158
8
7
153
3
94
1
27
16
5
1
6
25

49
45
2
2
44
1
27
0
8
5
1
0
2
7

Abbreviation: LARC, long-acting reversible contraception.
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Table 3 Characteristics of study population by use of LARC vs.
non-LARC method (n=351)
Characteristic
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Age
Race
Black
White
Others
Ethnicity
Hispanic
Non-Hispanic
Marital status
Married
Not married but
partnered
No partner
Current level of
training
Postgraduate year 1
Postgraduate year 2
Postgraduate year 3
Postgraduate year 4
Personal religion
Agnostic, Atheist, and
none
Hindu, Islamic, Buddhist,
other
Catholic
Christian, Mormon
Jewish
Protestant
Personal religion,
dichotomized
Agnostic, atheist, and
none
Any religion
Most important
reason for method
choice
Effective pregnancy
prevention
Convenient and easy
to use
Method is long acting
Bleeding, symptom, or
menstrual control
Others

LARC
(n=173)

Non-LARC/no
P-value
method (n=178)

Mean SD

Mean

SD

29.0
N

28.9
N

1.9
%

2.4
%

0.63
0.45

8
144
21

4.6
83.2
12.2

14
143
20

7.9
80.8
11.3

11
161

6.4
93.6

8
169

4.5
95.5

76
71

43.9
41.1

75
70

42.1
39.3

26

15.0

33

18.6

0.44

Table 4 Factors associated with current LARC use
Factor

Adjusted model

Ryan Program
Personal religion, dichotomized
Agnostic, Atheist, and none
All other religions
Most important reasons for method choice
Effective pregnancy prevention
Convenient and easy to use
Method is long acting
Bleeding, symptom, or menstrual control

RR
2.14

95% CI
1.63 2.80

0.76

0.64

0.92

3.48
3.05
4.14
1.81

1.46
1.26
1.75
0.72

8.28
7.39
9.80
4.57

Abbreviations: LARC, long-acting reversible contraception; RR, relative risk;
CI, confidence interval; Ryan Program, Ryan Residency Training Program.

0.68

0.47
47
42
42
42

27.1
24.3
24.3
24.3

37
49
41
51

20.8
27.5
23.0
28.7

67

38.7

35

19.7

11

6.4

12

6.7

28
36
14
17

16.2
20.8
8.1
9.8

42
55
20
14

23.6
30.9
11.2
7.9

<0.01

<0.01
67

38.7

35

19.7

106

61.3

143

80.3
<0.01

82

47.4

50

28.1

43

24.9

41

23.1

21
22

12.1
12.7

2
56

1.1
31.5

5

2.9

28

15.7

Notes: Column percentages do not always equal 100% as some survey questions
were not answered by the participants.
Abbreviations: SD, standard deviation; LARC, long-acting reversible contraception.

a rate more than 4 times higher than the general population.5
This percentage is remarkable, given current IUD and implant
use in the US. In addition, residents in Ryan-affiliated training programs were twice as likely to use LARC as residents
in non-affiliated programs.
Open Access Journal of Contraception 2017:8

Multiple studies have shown that level of knowledge
regarding contraception is an important factor in personal
contraceptive method choice.15,16 We found an association
between exposure to the Ryan Program and LARC use.
Residents who are more comfortable with the evidence supporting use of LARC methods may be more comfortable
using the method themselves. A survey of family planning
providers supports this conclusion and revealed that 42% of
these providers were themselves using a LARC method.15 Two
additional recent international surveys of female healthcare
providers corroborate these findings and one of these studies concluded that personal contraceptive choice influenced
contraceptive recommendations to patients.17,18
LARC uptake in the US is increasing; however, it is still
lower than many developed countries.19 Recent reports have
shown that use of LARC methods has grown 5-fold since
2002.4 However, the most recent national data indicate that
only 11.6% of women using contraception are using an IUD
or implant.5
Our study describes the contraceptive use of Ob/Gyn
residents in the US and evaluates the association of a formalized contraception and abortion curriculum on those
method choices. This study is unique in that the respondents are not only highly educated and insured, but are also
currently in training programs to become practicing Ob/
Gyns. Having insurance as well as familiarity with current
evidence theoretically eliminates two of the most common
barriers to increased LARC uptake. When not covered by
insurance, LARC is associated with an initial substantial
out-of-pocket expense and decreased LARC use.20 Although
it is possible that some respondents, particularly those training at a religiously affiliated residency programs, may not
have contraceptive coverage, we did not specifically ask this
question and therefore were unable to control this variable
in the analysis.
submit your manuscript | www.dovepress.com
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Our study had several strengths. Achieving adequate
responses to electronic surveys is difficult, with the mean
historical response rate being 37%.21 Our survey response
rate was 60%, which we believe is sufficiently high to minimize nonresponse bias.22 However, given that only 75% of
programs agreed to participate, our effective response rate
was lower (60% * 75%=45%). Even with this consideration,
we believe this survey to be among the largest contemporary
surveys of contraceptive use in US Ob/Gyn residents. Second,
although prior studies examined knowledge regarding LARC
as well as personal use of LARC in providers across different
specialties, our study explored LARC use in Ob/Gyn residents in training, a group that is expected to be knowledgeable
regarding all contraceptive methods.
Our study was not without limitations. We attempted to
sample a geographically diverse population of both Ryan and
non-Ryan Programs. However, we did not sample every US
Ob/Gyn residency program and, for efficiency, we did not invite
programs with a small number of residents. Yet we attempted
to minimize sample bias by stratifying programs by geographic
region and Ryan affiliation. Second, as a cross-sectional survey,
we could not establish causality. It is possible, for example,
that residents who selected a residency with a Ryan Program
are more likely to use LARC regardless of the educational
experience of the specific training program. We also did not
include timing of contraceptive initiation in our analysis; thus,
we could not establish temporal sequence. In addition, students
with a greater interest in family planning may be more likely
to choose a residency program with Ryan training. Lastly, as
mentioned earlier, there may be residual confounding that we
were unable to control in our analysis such as contraceptive
insurance coverage and resident choice of training program.
While our population is not representative of the national
population, we feel we have demonstrated that, as in the
Contraceptive CHOICE project, when knowledge, access,
and financial barriers to contraception are removed, women
are more likely to choose the most effective contraceptive
methods.7,8,15 Our study suggests that exposure to formalized
and evidence-based contraceptive and abortion curriculum
may result in a higher uptake of these methods.
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